机构：[1]School of Basic Medical Sciences, Southwest Medical University, Luzhou, 646000, Sichuan, China[2]Nucleic Acid Medicine of Luzhou Key Laboratory, Key Laboratory of Medical Electrophysiology, Ministry of Education & Medical Electrophysiological Key Laboratory of Sichuan Province, (Collaborative Innovation Center for Prevention of Cardiovascular Diseases), Institute of Cardiovascular Research, Southwest Medical University, Luzhou, 646000, Sichuan, China[3]Department of Neurosurgery, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China[4]Department of General Surgery (Thyroid Surgery), The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China[5]Metabolic Vascular Diseases Key Laboratory of Sichuan Province, Luzhou, 646000, Sichuan, China
This work was supported by the National Natural Science Foundation of China [grant number 82030007]; the Applied Basic Research Program of Sichuan Province [grant numbers 2023NSFSC1840, 2021YJ0200]; the Sichuan Science and Technology Program [grant numbers 2022YFS0630, 2022YFS0627, 2022YFS0578, 2022YFS0607]; the Science and Technology Project of Luzhou Government [grant numbers 2022YFS0630-B1, 2022YFS0627-A1, 2022YFS0614-A1]; and the Southwest Medical University [grant number 2021ZKMS005].
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类|3 区医学
小类|2 区药学
最新[2023]版：
大类|3 区医学
小类|2 区药学
第一作者：
第一作者机构：[1]School of Basic Medical Sciences, Southwest Medical University, Luzhou, 646000, Sichuan, China
通讯作者：
通讯机构：[1]School of Basic Medical Sciences, Southwest Medical University, Luzhou, 646000, Sichuan, China[2]Nucleic Acid Medicine of Luzhou Key Laboratory, Key Laboratory of Medical Electrophysiology, Ministry of Education & Medical Electrophysiological Key Laboratory of Sichuan Province, (Collaborative Innovation Center for Prevention of Cardiovascular Diseases), Institute of Cardiovascular Research, Southwest Medical University, Luzhou, 646000, Sichuan, China
推荐引用方式(GB/T 7714)：
Li Qiuhong,Chen Kexin,Zhang Tianyi,et al.Understanding sorafenib-induced ferroptosis and resistance mechanisms: Implications for cancer therapy[J].European journal of pharmacology.2023,955:175913.doi:10.1016/j.ejphar.2023.175913.
APA：
Li Qiuhong,Chen Kexin,Zhang Tianyi,Jiang Donghui,Chen Ligang...&Li Shengbiao.(2023).Understanding sorafenib-induced ferroptosis and resistance mechanisms: Implications for cancer therapy.European journal of pharmacology,955,
MLA：
Li Qiuhong,et al."Understanding sorafenib-induced ferroptosis and resistance mechanisms: Implications for cancer therapy".European journal of pharmacology 955.(2023):175913
